#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Isodicentric chromosome 15 syndrome Sickle cell disease Prodromal Alzheimer's disease Fragile X syndrome ABO haemolytic disease of newborn Follicle centre lymphoma follicular grade I II – III refractory Advanced systemic mastocytosis Breast angiosarcoma Leukocyte adhesion deficiency type I Insulinoma Porphyria non-acute Infertility male Spinal muscular atrophy Mycobacterium abscessus infection Hyperinsulinism More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Basic Information Wolfram syndrome – Basic Information Retinitis pigmentosa – Trials in Disease Factor VIII deficiency – Life with Disease VEXAS syndrome – Trials in Disease MELAS syndrome – Life with Disease Von Willebrand’s disease – Diagnostics SAPHO syndrome Advanced systemic mastocytosis Optic glioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nitrofurantoin Citric Acid Int-787 Alanine Betaxolol FOSMANOGEPIX VG801-2 Fluticasone Furoate CHONDROITIN SULFATE SODIUM Inupadenant Hydrochloride VMX-C001 Camizestrant Vancomycin Hydrochloride PF-07868489 Bempikibart Fluticasone Propionate Human Normal Immunoglobulin Interleukin-2 HYALURONIDASE Regorafenib More therapies…

    Learn about Your Condition

    Shprintzen-Goldberg syndrome Stargardt's disease Thymoma malignant Osteonecrosis of jaw Neonatal anoxia Hidradenitis Obesity Rectal cancer recurrent Renal cell carcinoma Hypertrophic scar Hot flush Glomerulonephritis chronic Gastric cancer Colour blindness Ovarian cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Testicular seminoma (pure)

  • Study on the Impact of Cisplatin and Drug Combination on Speech and Cognition in Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Testis cancer
    • Bladder cancer
    Investigated Drugs:
    • Bleomycin Sulfate Ph. Eur.
    • Mesna
    • Capecitabine
    Finland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!